These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2896254)

  • 1. P-fimbriae receptors in patients with chronic pyelonephritis.
    Jacobson SH; Källenius G; Lins LE; Svenson SB
    J Urol; 1988 May; 139(5):900-3. PubMed ID: 2896254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P-fimbriated Escherichia coli in adults with renal scarring and pyelonephritis.
    Jacobson SH
    Acta Med Scand Suppl; 1986; 713():1-64. PubMed ID: 2880464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence-activated cell analysis of P-fimbriae receptor accessibility on uroepithelial cells of patients with renal scarring.
    Jacobson S; Carstensen A; Källenius G; Svenson S
    Eur J Clin Microbiol; 1986 Dec; 5(6):649-54. PubMed ID: 3542529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibody response to P-fimbriae of Escherichia coli in patients with genitourinary infections].
    Kanai S; Miyake K; Agata N; Ohta M; Kato N
    Hinyokika Kiyo; 1990 Jan; 36(1):1-6. PubMed ID: 1968696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The role of fimbriae of Escherichia coli in urinary tract infections].
    Ishikawa S
    Hinyokika Kiyo; 1991 Sep; 37(9):953-6. PubMed ID: 1686148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Density and localization of P-fimbriae-specific receptors on mammalian cells: fluorescence-activated cell analysis.
    Svenson SB; Källenius G
    Infection; 1983; 11(1):6-12. PubMed ID: 6132882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective anti-idiotype antibodies in the primate model of pyelonephritis.
    Kaack MB; Martin LN; Svenson SB; Baskin G; Steele RH; Roberts JA
    Infect Immun; 1993 Jun; 61(6):2289-95. PubMed ID: 8099064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological response to the P fimbriae of uropathogenic Escherichia coli in pyelonephritis.
    de Ree JM; van den Bosch JF
    Infect Immun; 1987 Sep; 55(9):2204-7. PubMed ID: 2887515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serological response to P-fimbriae of Escherichia coli in patients with urinary tract infections.
    Agata N; Ohta M; Miyazawa H; Mori M; Kido N; Kato N
    Eur J Clin Microbiol Infect Dis; 1989 Feb; 8(2):156-9. PubMed ID: 2566483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gal-Gal pili vaccines prevent pyelonephritis by piliated Escherichia coli in a murine model. Single-component Gal-Gal pili vaccines prevent pyelonephritis by homologous and heterologous piliated E. coli strains.
    Pecha B; Low D; O'Hanley P
    J Clin Invest; 1989 Jun; 83(6):2102-8. PubMed ID: 2566625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of bacterial adherence in the initiation of clinical pyelonephritis.
    Svenson SB; Kallenius G
    Adv Nephrol Necker Hosp; 1986; 15():245-57. PubMed ID: 2869651
    [No Abstract]   [Full Text] [Related]  

  • 12. Interleukin-6 and interleukin-8 in serum and urine in patients with acute pyelonephritis in relation to bacterial-virulence-associated traits and renal function.
    Jacobson SH; Hylander B; Wretlind B; Brauner A
    Nephron; 1994; 67(2):172-9. PubMed ID: 7915403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental pyelonephritis in the monkey. VII. Ascending pyelonephritis in the absence of vesicoureteral reflux.
    Roberts JA; Suarez GM; Kaack B; Kallenius G; Svenson SB
    J Urol; 1985 Jun; 133(6):1068-75. PubMed ID: 2860250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of P-fimbrial-mediated adherence in pyelonephritis and persistence of uropathogenic Escherichia coli (UPEC) in the mammalian kidney.
    Lane MC; Mobley HL
    Kidney Int; 2007 Jul; 72(1):19-25. PubMed ID: 17396114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of pyelonephritis by immunization with P-fimbriae.
    Roberts JA; Hardaway K; Kaack B; Fussell EN; Baskin G
    J Urol; 1984 Mar; 131(3):602-7. PubMed ID: 6199527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoprotection of guinea pigs against experimental acute pyelonephritis after the administration of Escherichia coli purified fimbriae.
    Dima VF; Petrovici A; Dima SV; Petrovici M; Burghelea B
    Arch Roum Pathol Exp Microbiol; 1989; 48(3):215-25. PubMed ID: 2577515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody responses and protection from pyelonephritis following vaccination with purified Escherichia coli PapDG protein.
    Roberts JA; Kaack MB; Baskin G; Chapman MR; Hunstad DA; Pinkner JS; Hultgren SJ
    J Urol; 2004 Apr; 171(4):1682-5. PubMed ID: 15017266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic significance of P-fimbriated Escherichia coli in urinary tract infections.
    Domingue GJ; Roberts JA; Laucirica R; Ratner MH; Bell DP; Suarez GM; Kallenius G; Svenson S
    J Urol; 1985 Jun; 133(6):983-9. PubMed ID: 2860251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P-fimbriae studies on the diagnosis and prevention of acute pyelonephritis.
    Källenius G; Jacobson SH; Tullus K; Svenson SB
    Infection; 1985; 13 Suppl 2():S202-5. PubMed ID: 2865213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptors for pyelonephritogenic Escherichia coli in primates.
    Roberts JA; Kaack B; Källenius G; Möllby R; Winberg J; Svenson SB
    J Urol; 1984 Jan; 131(1):163-8. PubMed ID: 6140316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.